A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Corvus Pharmaceuticals, Inc.
SecuraBio
Fudan University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Arvinas Inc.
SciTech Development, Inc.
Barbara Ann Karmanos Cancer Institute